Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Resistance to anticoagulant rodenticides in Martinique could lead to inefficient rodent control in a context of endemic leptospirosis.

Marquez A, Khalil RA, Fourel I, Ovarbury T, Pinot A, Rosine A, Thalmensi G, Jaffory G, Kodjo A, Benoit E, Lattard V.

Sci Rep. 2019 Sep 17;9(1):13491. doi: 10.1038/s41598-019-49661-5.

2.

Intranasal dexmedetomidine in healthy beagles: An echocardiographic and pharmacokinetic/pharmacodynamic study.

Santangelo B, Harel M, Fourel I, Micieli F, Cataldi M, Segard-Weisse E, Portier K.

Vet J. 2019 Sep;251:105346. doi: 10.1016/j.tvjl.2019.105346. Epub 2019 Jul 27.

PMID:
31492384
3.

Pharmacokinetics of intramuscular alfaxalone and its echocardiographic, cardiopulmonary and sedative effects in healthy dogs.

Cruz-Benedetti IC, Bublot I, Ribas T, Fourel I, Vogl C, Dubois C, Milani M, Ida KK, Portier K.

PLoS One. 2018 Sep 24;13(9):e0204553. doi: 10.1371/journal.pone.0204553. eCollection 2018.

4.

Do bromadiolone treatments to control grassland water voles (Arvicola scherman) affect small mustelid abundance?

Fernandez-de-Simon J, Coeurdassier M, Couval G, Fourel I, Giraudoux P.

Pest Manag Sci. 2019 Apr;75(4):900-907. doi: 10.1002/ps.5194. Epub 2018 Oct 16.

PMID:
30175431
5.

Pharmacokinetics of low-dose methotrexate in healthy beagle dogs.

Rostang A, Mosca M, Jeannin M, Luissiez C, Berny P, Fourel I, Pin D, Prouillac C.

J Vet Pharmacol Ther. 2018 Oct;41(5):659-669. doi: 10.1111/jvp.12673. Epub 2018 Jun 12.

PMID:
29893406
6.

Liver and fecal samples suggest differential exposure of red fox (Vulpes vulpes) to trans- and cis-bromadiolone in areas from France treated with plant protection products.

Fourel I, Sage M, Benoit E, Lattard V.

Sci Total Environ. 2018 May 1;622-623:924-929. doi: 10.1016/j.scitotenv.2017.12.053. Epub 2017 Dec 13. No abstract available.

PMID:
29227943
7.

Population genetics, community of parasites, and resistance to rodenticides in an urban brown rat (Rattus norvegicus) population.

Desvars-Larrive A, Pascal M, Gasqui P, Cosson JF, Benoît E, Lattard V, Crespin L, Lorvelec O, Pisanu B, Teynié A, Vayssier-Taussat M, Bonnet S, Marianneau P, Lacôte S, Bourhy P, Berny P, Pavio N, Le Poder S, Gilot-Fromont E, Jourdain E, Hammed A, Fourel I, Chikh F, Vourc'h G.

PLoS One. 2017 Sep 8;12(9):e0184015. doi: 10.1371/journal.pone.0184015. eCollection 2017.

8.

Cis-bromadiolone diastereoisomer is not involved in bromadiolone Red Kite (Milvus milvus) poisoning.

Fourel I, Damin-Pernik M, Benoit E, Lattard V.

Sci Total Environ. 2017 Dec 1;601-602:1412-1417. doi: 10.1016/j.scitotenv.2017.06.011. Epub 2017 Jun 8.

9.

Core-shell LC-MS/MS method for quantification of second generation anticoagulant rodenticides diastereoisomers in rat liver in relationship with exposure of wild rats.

Fourel I, Damin-Pernik M, Benoit E, Lattard V.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Jan 15;1041-1042:120-132. doi: 10.1016/j.jchromb.2016.12.028. Epub 2016 Dec 21.

PMID:
28033586
10.

Management of Rodent Populations by Anticoagulant Rodenticides: Toward Third-Generation Anticoagulant Rodenticides.

Damin-Pernik M, Espana B, Lefebvre S, Fourel I, Caruel H, Benoit E, Lattard V.

Drug Metab Dispos. 2017 Feb;45(2):160-165. doi: 10.1124/dmd.116.073791. Epub 2016 Dec 1.

PMID:
27934637
11.

Development of an Ecofriendly Anticoagulant Rodenticide Based on the Stereochemistry of Difenacoum.

Damin-Pernik M, Espana B, Besse S, Fourel I, Caruel H, Popowycz F, Benoit E, Lattard V.

Drug Metab Dispos. 2016 Dec;44(12):1872-1880. Epub 2016 Sep 12.

12.

Comparison of the effects of an intravenous lidocaine infusion combined with 1% isoflurane versus 2% isoflurane alone on selected cardiovascular variables and recovery characteristics during equine general anaesthesia.

Cruz Benedetti IC, Nottrott K, Fourel I, Le Bris M, Mongellas E, Portier K.

Vet Anaesth Analg. 2017 Jan;44(1):63-69. doi: 10.1111/vaa.12376. Epub 2017 Feb 23.

PMID:
27103606
13.

New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) - The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations.

Matagrin B, Hodroge A, Montagut-Romans A, Andru J, Fourel I, Besse S, Benoit E, Lattard V.

FEBS Open Bio. 2013 Feb 16;3:144-50. doi: 10.1016/j.fob.2013.02.001. Print 2013.

14.

Bioaccumulation of chlorophacinone in strains of rats resistant to anticoagulants.

Vein J, Vey D, Fourel I, Berny P.

Pest Manag Sci. 2013 Mar;69(3):397-402. doi: 10.1002/ps.3367. Epub 2012 Oct 29.

PMID:
23109180
15.

VKORC1 mutations detected in patients resistant to vitamin K antagonists are not all associated with a resistant VKOR activity.

Hodroge A, Matagrin B, Moreau C, Fourel I, Hammed A, Benoit E, Lattard V.

J Thromb Haemost. 2012 Dec;10(12):2535-43. doi: 10.1111/jth.12019.

16.

Iophenoxic acid derivatives as markers of oral baits to wildlife. New tools for their detection in tissues of a game species and safety considerations for human exposure.

Sage M, Fourel I, Lahoreau J, Siat V, Berny P, Rossi S.

Environ Sci Pollut Res Int. 2013 May;20(5):2893-904. doi: 10.1007/s11356-012-1172-x. Epub 2012 Sep 22.

PMID:
23001758
17.

Development of a romifidine constant rate infusion with or without butorphanol for standing sedation of horses.

Ringer SK, Portier KG, Fourel I, Bettschart-Wolfensberger R.

Vet Anaesth Analg. 2012 Jan;39(1):12-20. doi: 10.1111/j.1467-2995.2011.00681.x.

PMID:
22151873
18.

Development of a xylazine constant rate infusion with or without butorphanol for standing sedation of horses.

Ringer SK, Portier KG, Fourel I, Bettschart-Wolfensberger R.

Vet Anaesth Analg. 2012 Jan;39(1):1-11. doi: 10.1111/j.1467-2995.2011.00653.x. Epub 2011 Nov 22.

PMID:
22103355
19.

Biochemical characterization of spontaneous mutants of rat VKORC1 involved in the resistance to antivitamin K anticoagulants.

Hodroge A, Longin-Sauvageon C, Fourel I, Benoit E, Lattard V.

Arch Biochem Biophys. 2011 Nov;515(1-2):14-20. doi: 10.1016/j.abb.2011.08.010. Epub 2011 Aug 31.

PMID:
21907178
20.

Comparison of xylazine-butorphanol and xylazine-morphine-ketamine infusions in horses undergoing a standing surgery.

Benredouane K, Ringer SK, Fourel I, Lepage OM, Portier KG, Bettschart-Wolfensberger R.

Vet Rec. 2011 Oct 1;169(14):364. doi: 10.1136/vr.d5333. Epub 2011 Sep 6. No abstract available.

PMID:
21896566
21.

Determination of bromadiolone residues in fox faeces by LC/ESI-MS in relationship with toxicological data and clinical signs after repeated exposure.

Sage M, Fourel I, Cœurdassier M, Barrat J, Berny P, Giraudoux P.

Environ Res. 2010 Oct;110(7):664-74. doi: 10.1016/j.envres.2010.07.009. Epub 2010 Aug 7.

PMID:
20692656
23.
24.

Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.

Fourel I, Cullen JM, Saputelli J, Aldrich CE, Schaffer P, Averett DR, Pugh J, Mason WS.

J Virol. 1994 Dec;68(12):8321-30.

25.

Human hepatocellular carcinoma transplanted in nude mice: a relevant experimental model to assess tumoral destruction by alcoholization.

Ain JF, Gouillat C, Bertrand S, Fourel I, Guillaud M, Saguier G, Trepo C.

J Surg Res. 1994 Sep;57(3):366-72.

PMID:
8072284
26.

Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.

Mason WS, Cullen J, Saputelli J, Wu TT, Liu C, London WT, Lustbader E, Schaffer P, O'Connell AP, Fourel I, et al.

Hepatology. 1994 Feb;19(2):398-411.

PMID:
8294097
28.

Histopathological assessment of tumoral destruction by alcoholization in an experimental model of human hepato-cellular carcinoma transplanted in nude mice.

Ain JF, Gouillat C, Bertrand S, Fourel I, Guillaud M, Saguier G, Trepo C.

Eur J Surg Oncol. 1993 Dec;19(6):561-6.

PMID:
8270043
29.

Animal models for the understanding and control of HBV and HDV infections.

Cova L, Fourel I, Vitvitski L, Lambert V, Chassot S, Hantz O, Trepo C.

J Hepatol. 1993;17 Suppl 3:S143-8. No abstract available.

PMID:
8509630
30.

Viral spliced RNA are produced, encapsidated and reverse transcribed during in vivo woodchuck hepatitis virus infection.

Hantz O, Baginski I, Fourel I, Chemin I, Trepo C.

Virology. 1992 Sep;190(1):193-200.

PMID:
1382340
31.
32.

Decreased replication capacity of a duck hepatitis B virus mutant with altered distal pre-S region.

Li JS, Fourel I, Jaquet C, Trépo C.

Virus Res. 1991 Jun;20(1):11-21.

PMID:
1927049
33.

Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks.

Fourel I, Hantz O, Watanabe KA, Jacquet C, Chomel B, Fox JJ, Trepo C.

Antimicrob Agents Chemother. 1990 Mar;34(3):473-5.

34.

Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein.

Lambert V, Fernholz D, Sprengel R, Fourel I, Deléage G, Wildner G, Peyret C, Trépo C, Cova L, Will H.

J Virol. 1990 Mar;64(3):1290-7.

35.

Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: a useful system for antiviral testing.

Fourel I, Gripon P, Hantz O, Cova L, Lambert V, Jacquet C, Watanabe K, Fox J, Guillouzo C, Trepo C.

Hepatology. 1989 Aug;10(2):186-91.

PMID:
2545588
36.

Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide.

Gripon P, Diot C, Thézé N, Fourel I, Loreal O, Brechot C, Guguen-Guillouzo C.

J Virol. 1988 Nov;62(11):4136-43.

37.

Main properties of duck hepatitis B virus DNA polymerase: comparison with the human and woodchuck hepatitis B virus DNA polymerases.

Fourel I, Hantz O, Cova L, Allaudeen HS, Trepo C.

Antiviral Res. 1987 Nov;8(4):189-99.

PMID:
3446017
38.

Maintenance of woodchuck hepatitis virus activity in woodchuck hepatocyte primary culture.

Thézé N, Gripon P, Fourel I, Hantz O, Trepo C, Guguen-Guillouzo C.

J Gen Virol. 1987 Apr;68 ( Pt 4):1029-39.

PMID:
3572356
39.

Evidence for the presence of duck hepatitis B virus in wild migrating ducks.

Cova L, Lambert V, Chevallier A, Hantz O, Fourel I, Jacquet C, Pichoud C, Boulay J, Chomel B, Vitvitski L, et al.

J Gen Virol. 1986 Mar;67 ( Pt 3):537-47.

PMID:
3005480

Supplemental Content

Loading ...
Support Center